
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
The U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Merck & Co Inc’s MRK Enflonsia (clesrovimab-cfor) as an option for the prevention of respiratory syncytial virus (RSV) …